Sectors
TCRX
TScan Therapeutics, Inc.
0.77
2 x 0.54
2 x 0.97
bid
ask
+
0.01
1.62%
10:28 AM
timesize
| Ytd | -23.43% | |
| 1y | -57.46% |
0.75
day range
0.77
0.72
52 week range
2.57
| Open | 0.75 | Prev Close | 0.75 | Low | 0.75 | High | 0.77 | Mkt Cap | 50.04M |
| Vol | 86.21K | Avg Vol | 591.27K | EPS | -0.90 | P/E | N/A | Forward P/E | -2.33 |
| Beta | 1.06 | Short Ratio | 9.02 | Inst. Own | 86.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 0.87 | 200-d Avg | 1.01 | 1yr Est | 12.14 |
| Income Statement | |||
| Total Revenue | 1.05M | ||
| Revenues (USD) | 1.05M | ||
| Gross Profit | 1.05M | ||
| Operating Expenses | 31.54M | ||
| Research and Development Expense | 23.40M | ||
| Selling, General and Administrative Expense | 8.14M | ||
| Operating Income | -30.49M | ||
| Interest Expense | 699.00K | ||
| Net Income | -30.36M | ||
| Net Income Common Stock | -30.36M | ||
| Net Income Common Stock (USD) | -30.36M | ||
| Consolidated Income | -30.36M | ||
| Earnings per Basic Share | -0.23 | ||
| Earnings per Basic Share (USD) | -0.23 | ||
| Earnings per Diluted Share | -0.23 | ||
| Earning Before Interest & Taxes (EBIT) | -29.66M | ||
| Earning Before Interest & Taxes (USD) | -29.66M | ||
| Weighted Average Shares | 129.95M | ||
| Weighted Average Shares Diluted | 129.95M | ||
| Balance Sheet | |||
| Cash and Equivalents | 105.19M | ||
| Cash and Equivalents (USD) | 105.19M | ||
| Investments | 47.00K | ||
| Investments Non-Current | 47.00K | ||
| Current Assets | 104.40M | ||
| Property, Plant & Equipment Net | 61.97M | ||
| Total Assets | 171.45M | ||
| Debt Current | 19.42M | ||
| Total Debt | 90.89M | ||
| Current Liabilities | 30.96M | ||
| Debt Non-Current | 71.47M | ||
| Total Liabilities | 102.43M | ||
| Accumulated Retained Earnings (Deficit) | -563.89M | ||
| Shareholders Equity | 69.02M | ||
| Shareholders Equity (USD) | 69.02M | ||
| Assets Non-Current | 67.05M | ||
| Total Debt (USD) | 90.89M | ||
| Deferred Revenue | 586.00K | ||
| Liabilities Non-Current | 71.47M | ||
| Trade and Non-Trade Payables | 3.12M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 699.00K | ||
| Net Cash Flow from Financing | 99.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -27.90M | ||
| Capital Expenditure | -465.00K | ||
| Issuance (Purchase) of Equity Shares | 99.00K | ||
| Net Cash Flow from Investing | -465.00K | ||
| Net Cash Flow from Operations | -27.53M | ||
| Share Based Compensation | 2.36M | ||